Role of telomerase in the tumour microenvironment.
Ning LiuXue-Hua GuoJun-Ping LiuYu-Sheng CongPublished in: Clinical and experimental pharmacology & physiology (2019)
Telomeres are specialized genomic structures that protect chromosomal ends to maintain genomic stability. Telomeric length is primarily regulated by the telomerase complex, essentially consisting of an RNA template (TERC), an enzymatic subunit (telomerase reverse transcriptase, TERT). In humans, telomerase activity is repressed during embryonic differentiation and is absent in most somatic cells. However, it is upregulated or reactivated in 80%-90% of the primary tumours in humans. The human TERT (hTERT) plays a pivotal role in cellular immortality and tumourigenesis. However, the molecular mechanisms of telomerase functioning in cancer have not been fully understood beyond the telomere maintenance. Several research groups, including ours, have demonstrated that hTERT possesses vital functions independent of its telomere maintenance, including angiogenesis, inflammation, cancer cell stemness, and epithelial-mesenchymal transformation (EMT). All these telomere-independent activities of hTERT may contribute to the regulation of the dynamics and homeostasis of the tumour microenvironment (TME), thereby promoting tumour growth and development. Cancer progression and metastasis largely depend upon the interactions between cancer cells and their microenvironment. In this review, the involvement of TERT in the tumour microenvironment and the underlying implications in cancer therapeutics have been summarized.
Keyphrases
- stem cells
- papillary thyroid
- squamous cell
- endothelial cells
- copy number
- epithelial mesenchymal transition
- oxidative stress
- gene expression
- induced apoptosis
- lymph node metastasis
- bone marrow
- cell death
- palliative care
- dna damage
- cell cycle arrest
- vascular endothelial growth factor
- signaling pathway
- endoplasmic reticulum stress
- young adults
- dna repair
- wound healing
- pluripotent stem cells
- molecularly imprinted
- cancer stem cells